It’s the best new thing we’ve done for patients and providers in the last decade, easily,” says Dr. Stacey Blyth, a family ...
Early treatment with a newer targeted medicine, daratumumab, may help people with high-risk smoldering myeloma live longer and may delay the disease from becoming active. The medicine might have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results